Concepedia

Lipoprotein apheresis in patients with peripheral artery disease and lipoprotein(a)-hyperlipoproteinemia: 2-year follow-up of a prospective single center study

Wolfram C. Poller, Axel Berger, Henryk Dreger, Stanislao Morgera, Kathrin Enke-Melzer

Atherosclerosis Supplements · 2017 · 26 citations · 25 references

Concepts

MedicineCardiologyHematologyLipid BiochemistryVascular SurgeryCardiovascular DiseaseLipid DisordersLipid-lowering TherapyLipoprotein AnalysisLipoprotein MetabolismPeripheral Arterial DiseaseAtherosclerotic Lipid AccumulationAtherosclerotic Peripheral DiseaseFollow-up DurationLipid ApheresisLipoprotein(a) ElevationLipoprotein(a) Lowering TherapyPeripheral Artery Disease TreatmentTherapeutic Apheresis

References

25

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

Alberico L. Catapano, Ian Graham, Guy De Backer et al. · European Heart Journal · 2016 · 3.2K citations · Full text

Medicine, Internal Medicine, Epidemiology +11

Effects of Torcetrapib in Patients at High Risk for Coronary Events

Philip J. Barter, Mark J. Caulfield, Mats Eriksson et al. · New England Journal of Medicine · 2007 · 3.1K citations · Full text

Medicine, Cardiology, Pharmacology +14

Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy

New England Journal of Medicine · 2011 · 2.9K citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +9

Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events

Jennifer G. Robinson, Michel Farnier, Michel Krempf et al. · New England Journal of Medicine · 2015 · 2.3K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome

Gregory G. Schwartz, Anders Olsson, Markus Abt et al. · New England Journal of Medicine · 2012 · 2K citations · Full text

Medicine, Cardiology, Pharmacology +17